Salud financiera de hoja de balance de Hikma Pharmaceuticals
Salud financiera controles de criterios 4/6
Hikma Pharmaceuticals tiene un patrimonio de accionistas total de $2.2B y una deuda total de $1.1B, lo que sitúa su ratio deuda-patrimonio en 50.9%. Sus activos y pasivos totales son $4.7B y $2.5B respectivamente. El BAIT de Hikma Pharmaceuticals es de $619.0M, por lo que su ratio de cobertura de intereses es de 9.4. Tiene efectivo e inversiones a corto plazo que ascienden a $229.0M.
Información clave
50.9%
Ratio deuda-patrimonio
US$1.13b
Deuda
| Ratio de cobertura de intereses | 9.4x |
| Efectivo | US$229.00m |
| Patrimonio | US$2.21b |
| Total pasivo | US$2.47b |
| Activos totales | US$4.68b |
Actualizaciones recientes sobre salud financiera
Is Hikma Pharmaceuticals (LON:HIK) A Risky Investment?
Apr 02
Does Hikma Pharmaceuticals (LON:HIK) Have A Healthy Balance Sheet?
Dec 27Hikma Pharmaceuticals (LON:HIK) Has A Pretty Healthy Balance Sheet
Sep 19Is Hikma Pharmaceuticals (LON:HIK) A Risky Investment?
Jun 21Hikma Pharmaceuticals (LON:HIK) Has A Pretty Healthy Balance Sheet
Mar 14Does Hikma Pharmaceuticals (LON:HIK) Have A Healthy Balance Sheet?
Sep 27Recent updates
Is Hikma Pharmaceuticals PLC (LON:HIK) Trading At A 29% Discount?
Apr 24Is Hikma Pharmaceuticals (LON:HIK) A Risky Investment?
Apr 02Hikma Pharmaceuticals PLC's (LON:HIK) Share Price Matching Investor Opinion
Feb 25Does Hikma Pharmaceuticals (LON:HIK) Have A Healthy Balance Sheet?
Dec 27An Intrinsic Calculation For Hikma Pharmaceuticals PLC (LON:HIK) Suggests It's 43% Undervalued
Dec 12Hikma Pharmaceuticals (LON:HIK) Has A Pretty Healthy Balance Sheet
Sep 19Calculating The Intrinsic Value Of Hikma Pharmaceuticals PLC (LON:HIK)
Sep 01Is Hikma Pharmaceuticals (LON:HIK) A Risky Investment?
Jun 21Hikma Pharmaceuticals PLC's (LON:HIK) Intrinsic Value Is Potentially 28% Above Its Share Price
Jun 02Hikma Pharmaceuticals (LON:HIK) Has A Pretty Healthy Balance Sheet
Mar 14Calculating The Intrinsic Value Of Hikma Pharmaceuticals PLC (LON:HIK)
Feb 21Does Hikma Pharmaceuticals (LON:HIK) Have A Healthy Balance Sheet?
Sep 27Hikma Pharmaceuticals PLC's (LON:HIK) Intrinsic Value Is Potentially 19% Below Its Share Price
Jun 24These 4 Measures Indicate That Hikma Pharmaceuticals (LON:HIK) Is Using Debt Reasonably Well
Jun 06Here's Why Hikma Pharmaceuticals (LON:HIK) Can Manage Its Debt Responsibly
Feb 26Hikma Pharmaceuticals PLC's (LON:HIK) Intrinsic Value Is Potentially 92% Above Its Share Price
Dec 01Is Hikma Pharmaceuticals (LON:HIK) Using Too Much Debt?
Nov 11Is There An Opportunity With Hikma Pharmaceuticals PLC's (LON:HIK) 32% Undervaluation?
Sep 02Is Hikma Pharmaceuticals (LON:HIK) A Risky Investment?
Aug 09Hikma Pharmaceuticals PLC (LON:HIK) Shares Could Be 26% Below Their Intrinsic Value Estimate
May 21Hikma Pharmaceuticals (LON:HIK) Seems To Use Debt Quite Sensibly
May 03It's Unlikely That Hikma Pharmaceuticals PLC's (LON:HIK) CEO Will See A Huge Pay Rise This Year
Apr 16How Does Hikma Pharmaceuticals PLC (LON:HIK) Stand Up To These Simple Dividend Safety Checks?
Apr 13Hikma Pharmaceuticals PLC (LON:HIK) Looks Interesting, And It's About To Pay A Dividend
Mar 14Hikma Pharmaceuticals PLC Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Feb 28I Ran A Stock Scan For Earnings Growth And Hikma Pharmaceuticals (LON:HIK) Passed With Ease
Feb 22Is There An Opportunity With Hikma Pharmaceuticals PLC's (LON:HIK) 23% Undervaluation?
Feb 03Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo ($2.1B) de HIK superan a sus pasivos a corto plazo ($1.3B).
Pasivo a largo plazo: Los activos a corto plazo de HIK ($2.1B) superan a sus pasivos a largo plazo ($1.1B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: La relación deuda neta-capital de HIK (40.6%) se considera alta.
Reducción de la deuda: El ratio deuda-patrimonio de HIK ha crecido de 36.1% a 50.9% en los últimos 5 años.
Cobertura de la deuda: La deuda de HIK está bien cubierta por el flujo de caja operativo (54%).
Cobertura de intereses: Los pagos de intereses de la deuda de HIK están bien cubiertos por el BAIT (9.4x cobertura).